Public Health Agency of Sweden, Solna, Sweden.
European Programme for Public Health Microbiology Training (EUPHEM), European Centre for Disease Prevention and Control (ECDC), Solna, Sweden.
Euro Surveill. 2019 Jul;24(28). doi: 10.2807/1560-7917.ES.2019.24.28.1800397.
IntroductionSequence-based typing of hepatitis A virus (HAV) is important for outbreak detection, investigation and surveillance. In 2013, sequencing was central to resolving a large European Union (EU)-wide outbreak related to frozen berries. However, as the sequenced HAV genome regions were only partly comparable between countries, results were not always conclusive.AimThe objective was to gather information on HAV surveillance and sequencing in EU/European Economic Area (EEA) countries to find ways to harmonise their procedures, for improvement of cross-border outbreak responses.MethodsIn 2014, the European Centre for Disease Prevention and Control (ECDC) conducted a survey on HAV surveillance practices in EU/EEA countries. The survey enquired whether a referral system for confirming primary diagnostics of hepatitis A existed as well as a central collection/storage of hepatitis A cases' samples for typing. Questions on HAV sequencing procedures were also asked. Based on the results, an expert consultation proposed harmonised procedures for cross-border outbreak response, in particular regarding sequencing. In 2016, a follow-up survey assessed uptake of suggested methods.ResultsOf 31 EU/EEA countries, 23 (2014) and 27 (2016) participated. Numbers of countries with central collection and storage of HAV positive samples and of those performing sequencing increased from 12 to 15 and 12 to 14 respectively in 2016, with all countries typing an overlapping fragment of 218 nt. However, variation existed in the sequenced genomic regions and their lengths.ConclusionsWhile HAV sequences in EU/EEA countries are comparable for surveillance, collaboration in sharing and comparing these can be further strengthened.
引言
基于序列的甲型肝炎病毒(HAV)分型对于暴发检测、调查和监测至关重要。2013 年,测序在解决与冷冻浆果有关的欧盟(EU)范围内的大规模暴发中发挥了核心作用。然而,由于测序的 HAV 基因组区域在国家之间仅部分可比,因此结果并不总是确定的。
目的
本研究旨在收集欧盟/欧洲经济区(EEA)国家中 HAV 监测和测序的信息,以找到协调其程序的方法,从而改善跨境暴发应对。
方法
2014 年,欧洲疾病预防控制中心(ECDC)对欧盟/EEA 国家的 HAV 监测实践进行了调查。该调查询问是否存在确认甲型肝炎初步诊断的转诊系统,以及是否有集中收集/储存甲型肝炎病例样本进行分型。还询问了关于 HAV 测序程序的问题。根据结果,专家咨询提出了跨境暴发应对的协调程序,特别是关于测序的程序。2016 年,一项后续调查评估了建议方法的采用情况。
结果
在 31 个欧盟/EEA 国家中,有 23 个(2014 年)和 27 个(2016 年)国家参与了调查。2016 年,有中央收集和储存 HAV 阳性样本的国家以及进行测序的国家数量分别从 12 个增加到 15 个和 12 个增加到 14 个,所有国家都对 218 个核苷酸重叠片段进行了分型。然而,测序的基因组区域及其长度存在差异。
结论
虽然欧盟/EEA 国家的 HAV 序列在监测方面具有可比性,但在共享和比较这些序列方面可以进一步加强合作。